Watch CBS News
A Food and Drug Administration advisory panel voted to recommend Moderna's COVID-19 vaccine for emergency use authorization on Thursday. Meanwhile the rollout of Pfizer's vaccine to frontline health care workers continues. Columbia University professor of epidemiology and medicine Dr. Wafaa El-Sadr joins CBSN's "Red & Blue" anchor Elaine Quijano with more on what the safety data shows.
A second coronavirus vaccine could begin shipping this weekend that will provide millions of additional doses to Americans. This comes as the U.S. sets another deadly record as the pandemic surges. Jonathan Vigliotti reports.
Vials of Pfizer's COVID vaccine were found to contain an extra dose as a second vaccine is on its way to approval. Errol Barnett has more.
The FDA and Pfizer have given slightly different advice on how the extra doses should be used — or not used.
Members of an FDA advisory panel voted 20-0 to recommend Moderna's COVID-19 vaccine for emergency use. The FDA could authorize it within days, along with the Pfizer vaccine that health care workers started receiving this week. CBS New York's Dr. Max Gomez answers some common questions about the new vaccines on CBSN NY.
The FDA is considering emergency authorization for the Moderna coronavirus vaccine, as the nation continues to break records for daily new cases and deaths. Jennifer Gommerman, a professor of immunology at the University of Toronto, joins CBSN to talk more about the Moderna vaccine and the latest developments with the Pfizer doses.
A second COVID-19 vaccine by Moderna could inch closer to approval in the U.S. on Thursday. The Pfizer vaccine is already being distributed at hospitals and nursing homes across the country. The massive vaccination effort comes as the number of new COVID-19 infections continues to break records in the U.S. David Begnaud reports.
Doctors across the nation this week expected to receive the Pfizer vaccine with five doses in each vial. But to their surprise, they've found there may be more full doses available in each vial than previously thought. Errol Barnett reports.
Food and Drug Administration advisers are holding a key meeting Thursday to consider approving Moderna's coronavirus vaccine candidate for emergency use. CBS News correspondent David Begnaud and internal medicine physician Dr. Shoshana Ungerleider join CBSN with the latest on the United States' dire fight against the deadly disease, including extra doses in Pfizer's vaccine vials as well as concerns about rare allergic reactions.
Pfizer and Moderna could be looking at a big check once their first round of COVID vaccines are distributed, despite a non-lucrative market and pressure to keep costs low. But the key for both companies may lie in the patenting process. Quartz reporter Annalisa Merelli joined CBSN AM to explain how the COVID vaccine compares to other vaccines on the market and why the mRNA patent could have larger implications outside of coronavirus. She also gave insight to life inside Bergamo, Italy, one of the hardest-hit town earlier on in the pandemic.
By the end of the week, the U.S. could have two approved COVID-19 vaccines. The first, by Pfizer, is already being administered to frontline health care workers across the nation. "CBS This Morning" lead national correspondent David Begnaud got an exclusive look as nearly 5,000 doses arrived at the UC Davis Medical Center in Sacramento, California.
Americans start to get vaccinated against COVID-19 as deaths cross 300,000. Dr. David Agus joins "CBS This Morning" to explain the process, and how long it will take.
Kathrin Jansen saw the deadly impact of COVID-19 in New York and it fueled her desire to develop a vaccine. 60 Minutes reports, Sunday.
A second coronavirus vaccine could be made available in the U.S. as early as this week. The FDA is expected to authorize Moderna's vaccine for emergency use as cases skyrocket this holiday season. Dr. Leo Nissola is a medical expert and immunotherapy scientist. He joined CBSN to discuss the latest.
Doses of Pfizer's COVID-19 vaccine have been distributed across the U.S., and health care workers are among the first to be vaccinated. Casey Pickering is an ICU nurse manager for the Kansas University Health System and was among the first of the medical staff to get vaccinated there. They joined CBSN to discuss.
The FDA said the Moderna vaccine overall is 94.5% effective and 100% effective in people 65 and over.
Moderna's coronavirus vaccine could soon be part of America's largest mass vaccination effort. The Food and Drug Administration said the vaccine is highly effective and there are "no specific safety concerns," and a panel is expected to consider the pharmaceutical company's application for emergency use this week. This comes as distribution ramps up for Pfizer's vaccine and health care systems are stretched thin as coronavirus infections skyrocket. CBS News correspondent Mola Lenghi reports on the latest developments from New York City, CBS News chief congressional correspondent Nancy Cordes reports from Washington on the need for funding to fight COVID-19, and Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and the former acting director of the Centers for Disease Control and Prevention, joined CBSN to discuss.
The U.S. could be days away from authorizing a second coronavirus vaccine as both coasts see cases surge. CBS News correspondent David Begnaud reports on California hospitals grappling with a rising infection rate and Dr. Neeta Ogden, internal medicine specialist and immunologist, joined CBSN to discuss the how some states are struggling with vaccine funding and the Food and Drug Administration's authorization of the first over-the-counter rapid test.
A massive nationwide vaccination effort has begun in the U.S. as hospitals continue filling up with COVID-19 patients fighting for their lives. The nation has surpassed 300,00 deaths from the virus. Dr. Uché Blackstock joins CBSN to talk about the Pfizer and Moderna vaccines and what Americans need to do to fight the pandemic in the meantime.
The U.S. is ramping up its vaccine rollout, as the country surpasses 300,000 virus-related deaths and the Food and Drug Administration clears a path for a second vaccine, by Moderna. CBS News correspondent David Begnaud reports on the second day of the rollout as the virus arrives at some hospitals and Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss vaccines for children and pregnant women, coronavirus mutations and more.
Kathrin Jansen saw the deadly impact of COVID-19 in New York and it fueled her desire to develop a vaccine. 60 Minutes reports, Sunday.
Frontline workers across the U.S. lined up to get their first doses of the coronavirus vaccine. Mola Lenghi has the latest.
Science writer and New York Times columnist Carl Zimmer joined "Red and Blue" to break down how the Pfizer vaccine works and what hurdles might come up in the vaccine rollout.
The coronavirus vaccine transportation is a massive logistical challenge. Kris Van Cleave takes a closer look.
The U.S. is launching the largest vaccination effort in the nation's history on Monday, as cargo trucks and planes began delivering millions of doses of Pfizer's vaccine. CBS News correspondent David Begnaud reports on how hospitals are preparing for distribution, and Dr. Ron Elfenbein, medical director and owner of First Call Medical Center, joined CBSN to discuss how the vaccines will be administered to priority groups.
The 2025 government shutdown entered its sixth day on Monday with no signs of an imminent resolution. Follow live updates here.
The state of Illinois and city of Chicago are suing the Trump administration over their plans to deploy the National Guard.
Trump wants Israeli and Hamas negotiators to "move fast" in new talks aimed at securing a ceasefire in the Gaza war, spurred by his 20-point plan.
The Supreme Court on Monday said it will not take up a bid by Ghislaine Maxwell to overturn her 2021 conviction for sex trafficking.
Paramount, a Skydance Corporation, has announced the acquisition of The Free Press. Its co-founder and CEO, Bari Weiss, will join CBS News as editor-in-chief.
Nobel Prize committee chair says discoveries by the trio of researchers were "decisive for our understanding of how the immune system functions."
Mark Sanchez was hospitalized with multiple stab wounds following a violent altercation over the weekend.
Treasury Secretary Scott Bessent said Bisignano will continue to lead the Social Security Administration while also taking on the new IRS role.
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.